Indefinite Delivery Contract SPE2DX15D9310

This federal contract IDV award, with an ID of SPE2DX15D9310, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities worldwide.

The task orders issued under this IDC cover a wide variety of specialized pharmaceutical products such as Xolair, Trikafta, Keytruda, Botox, Nucala, and various other prescription drugs and medical supplies. These delivery orders are predominantly awarded as firm fixed-price contracts and span multiple medical domains, including oncology treatments, contraceptives, auto-injectors, and specialized pharmaceuticals. The contract does not utilize any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across these diverse product categories.